265
Participants
Start Date
April 30, 2004
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
activated recombinant human factor VII
Novo Nordisk Investigational Site, Shatin
Novo Nordisk Investigational Site, Taipei
Novo Nordisk Investigational Site, Aarhus
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Berlin
Novo Nordisk Investigational Site, Marseille
Novo Nordisk Investigational Site, Córdoba
Novo Nordisk Investigational Site, Caen
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Madrid
Novo Nordisk Investigational Site, Majadahonda
Novo Nordisk Investigational Site, Palermo
Novo Nordisk Investigational Site, Toulouse
Novo Nordisk Investigational Site, Grenoble
Novo Nordisk Investigational Site, Nantes
Novo Nordisk Investigational Site, Münster
Novo Nordisk Investigational Site, Angers
Novo Nordisk Investigational Site, Lille
Novo Nordisk Investigational Site, Heidelberg
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Paris
Novo Nordisk Investigational Site, Olomouc
Novo Nordisk Investigational Site, Napoli
Novo Nordisk Investigational Site, München
Novo Nordisk Investigational Site, Limoges
Novo Nordisk Investigational Site, Ulm
Novo Nordisk Investigational Site, Villejuif
Novo Nordisk Investigational Site, Vienna
Novo Nordisk Investigational Site, Prague
Novo Nordisk Investigational Site, Helsinki
Novo Nordisk Investigational Site, Clichy
Novo Nordisk Investigational Site, Nice
Novo Nordisk Investigational Site, Leipzig
Novo Nordisk Investigational Site, Katowice
Novo Nordisk Investigational Site, Krakow
Novo Nordisk Investigational Site, Warsaw
Novo Nordisk Investigational Site, Badalona
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Barcelona
Novo Nordisk Investigational Site, Leeds
Novo Nordisk Investigational Site, London
Novo Nordisk Investigational Site, Oxford
Lead Sponsor
Novo Nordisk A/S
INDUSTRY